Atezolizumab (Tecentriq) plus chemotherapy after surgery did not improve survival in high-risk triple-negative breast cancer, according to a global phase 3 trial.
The LumiSystem is a detection tool that uses fluorescence imaging technology during lumpectomy, offering a more complete resection vs other detection systems that evaluate tissue after surgical ...
2. Ovarian Cancer: Research indicates that a woman's chance of developing ovarian cancer may be influenced by hormonal factors, such as the number of ovulatory cycles she undergoes. Disorders that ...
The decline in cancer incidence among men and increase among women has narrowed the male‐to-female cancer incidence rate ratio from a peak of 1.6 in 1992 to 1.1 in 2021. In people aged 50-64 years, ...
The Chamber of Washington County has announced its first-ever Legacy Award recipient, Adna “Ad” Fulton. According to a news release, Fulton is recognized for his contributions to the community and his ...
It's not even the half marathon distance of 13.1 miles. The trek from the SeaWalk Pavilion to Pete's Bar may not measure up in the athletic category to some of the other events on the schedule for the ...
While pregnant, Susana Demore was diagnosed with Triple Negative Breast Cancer. After beating it, she has embraced significant lifestyle changes.
SEATTLE - Atossa Therapeutics, Inc. (NASDAQ:ATOS), a biopharmaceutical company focusing on breast cancer treatment with a market capitalization of $107 million, has encountered a challenge in its ...
Among patients with advanced PIK3CA-mutated, HR-positive/HER2-negative breast cancer, Itovebi-based treatment generated positive overall survival results.
The use of radiation therapy has become a staple in breast cancer treatment, with benefits seen in node-positive patients, those with locally advanced disease, and those with large-sized tumors.
Patients diagnosed with more advanced breast cancer are more likely to have cardiovascular disease, a large study suggests.
After a bad relationship and a cancer journey, this letter writer wonders about finding love again. How can she be open to ...